Table 5.
Flow cytometry analysis of PI-stained MOLT-4 cells treated with Pd@W.tea NPs
| Cell cycle phase | Cells (%)
|
|||||
|---|---|---|---|---|---|---|
| 12 h
|
24 h
|
48 h
|
||||
| Control | Treated | Control | Treated | Control | Treated | |
| G0/G1 | 55.34±0.06 | 52.01±0.45 | 57.20±0.29 | 58.11±0.52 | 50.64±0.32 | 48.24±0.68 |
| G2/M | 18.85±0.76 | 24.00*±0.41 | 14.2±0.26 | 19.29*±0.35 | 16.30±0.22 | 26.06*±0.93 |
| S | 22.01±0.06 | 20.03±0.33 | 20.3±0.06 | 21.6±0.12 | 20.86±0.61 | 20.35±0.18 |
| SubG0/G1 | 3.8±0.23 | 4.00±0.28 | 2.30±0.34 | 1.00±0.20 | 12.20±0.46 | 5.35*±0.56 |
Notes: Values are expressed as mean ± SD of triplicate experiments. Data has been analyzed using one-way ANOVA with Tukey’s test for post hoc comparison.
*
For each treatment period is significantly (P>0.05) different from control.
Abbreviations: ANOVA, analysis of variance; MOLT-4, human leukemia cell line; NPs, nanoparticles; Pd, palladium; PI, propidium iodide; W.tea, white tea.